Correspondence from Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW)
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: July 7, 2026 · CIK: 0001130598 · Accession: 0001104659-26-081336
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-297195
Letter
Traws Pharma, Inc.
12 Penns Trail
Newtown, PA 18940
(267) 759-3680
July 7, 2026
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: Traws Pharma, Inc.
Registration Statement on Form S-3
File No. 333-297195
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Traws Pharma, Inc., a Delaware corporation (the “Registrant”), hereby respectfully requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-297195), to become effective on Thursday, July 9, 2026, at 5:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.
The Registrant understands that the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes its counsel, Christopher L. Tinen, Esq. of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration. Please contact Mr. Tinen at (858) 910-4809 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
Very truly yours,
Traws Pharma, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Traws Pharma, Inc.
12 Penns Trail
Newtown, PA 18940
(267) 759-3680
July 7, 2026
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: Traws Pharma, Inc.
Registration Statement on Form S-3
File No. 333-297195
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Traws Pharma, Inc., a Delaware corporation (the “Registrant”), hereby respectfully
requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the
above-referenced Registration Statement on Form S-3 (File No. 333-297195), to become effective on Thursday, July 9, 2026, at 5:00 p.m.,
Eastern Time, or as soon as reasonably practicable thereafter.
The Registrant understands
that the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal
securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes
its counsel, Christopher L. Tinen, Esq. of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration. Please
contact Mr. Tinen at (858) 910-4809 with any questions you may have concerning this request, and please notify him when this request for
acceleration has been granted.
Very truly yours,
Traws Pharma, Inc.
By:
/s/ Charles Parker
Name:
Charles Parker
Title:
Chief Financial Officer
cc: Christopher L. Tinen, Snell & Wilmer L.L.P.